Salarius Pharmaceuticals Inc (NAS:SLRX)
$ 1.67 0.0065 (0.39%) Market Cap: 2.41 Mil Enterprise Value: -558,000.00 PE Ratio: 0 PB Ratio: 0.82 GF Score: 29/100

Q1 2020 Salarius Pharmaceuticals Inc Earnings Call Transcript

May 14, 2020 / 08:30PM GMT
Release Date Price: $167.96 (+0.87%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2020 Salarius Pharmaceuticals earnings webcast and conference call. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Mr. Jason Rando. Thank you. Please go ahead, sir.

Jason Rando
Tiberend Strategic Advisors, Inc. - IR

Good afternoon, everyone, and thank you for joining Salarius Pharmaceuticals's 2020 first quarter financial and corporate results call. Earlier this afternoon, Salarius issued a press release detailing its financial results for the three months ended March 31, 2020, which we encourage listeners to read. The press release can be found in the news and events section of salariuspharma.com. Salarius also filed a 10-Q this afternoon which is available on salariuspharma.com and sec.gov.

Before beginning today's call, I would like to make the following statements. Today we'll be making certain forward-looking statements about future expectations, plan, events, and circumstances, including statements about our strategy,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot